NCT05836584 2026-04-21
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
Sichuan University
Eastern Cooperative Oncology Group
Mayo Clinic
Fujian Medical University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Fudan University
Sohag University
First Affiliated Hospital Xi'an Jiaotong University
Shanghai Cancer Hospital, China
Fudan University
Sun Yat-sen University